Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma

Background/Aim: Trabectedin is a synthetic antineoplastic agent approved for advanced soft tissue sarcoma (STS) in Japan. The aim of this study was to evaluate the efficacy and safety of the Japan-approved dose of trabectedin for advanced STS. Patients and Methods: We retrospectively reviewed 38 pat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:In Vivo
Main Authors: KAWAGUCHI, KUNIKI, NAKANO, KENJI, URASAKI, TETSUYA, FUKUDA, NAOKI, TAIRA, SHINICHIRO, ONO, MAKIKO, TOMOMATSU, JUNICHI, NISHIZAWA, MASATOSHI, AE, KEISUKE, MATSUMOTO, SEIICHI, TAKAHASHI, SHUNJI
Format: Artigo
Jezik:Inglês
Izdano: International Institute of Anticancer Research 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755008/
https://ncbi.nlm.nih.gov/pubmed/31471412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11644
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki